According to Zacks, “LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company’s general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy. “
A number of other equities research analysts have also recently commented on the stock. Credit Suisse Group AG reissued a buy rating and issued a $64.00 price objective on shares of LifePoint Hospitals in a research note on Tuesday, August 30th. TheStreet cut shares of LifePoint Hospitals from a buy rating to a hold rating in a research note on Thursday, August 25th. Raymond James Financial Inc. lowered their price objective on shares of LifePoint Hospitals from $75.00 to $65.00 and set an outperform rating on the stock in a research note on Tuesday, August 2nd. RBC Capital Markets reissued an outperform rating and issued a $77.00 price objective (down from $84.00) on shares of LifePoint Hospitals in a research note on Monday, August 1st. Finally, Wedbush reissued a neutral rating and issued a $66.00 price objective (down from $80.00) on shares of LifePoint Hospitals in a research note on Monday, August 1st. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the company’s stock. LifePoint Hospitals currently has an average rating of Hold and an average price target of $72.06.
Shares of LifePoint Hospitals (NASDAQ:LPNT) opened at 58.36 on Wednesday. The stock has a market capitalization of $2.49 billion, a P/E ratio of 19.43 and a beta of 0.88. LifePoint Hospitals has a 1-year low of $54.82 and a 1-year high of $76.39. The stock has a 50 day moving average of $57.45 and a 200-day moving average of $64.16.
LifePoint Hospitals (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, July 29th. The company reported $0.71 EPS for the quarter, missing the Zacks’ consensus estimate of $0.90 by $0.19. The business earned $1.59 billion during the quarter, compared to analyst estimates of $1.61 billion. LifePoint Hospitals had a net margin of 2.08% and a return on equity of 7.14%. LifePoint Hospitals’s revenue was up 25.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. Equities research analysts predict that LifePoint Hospitals will post $3.51 earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Fuller & Thaler Asset Management Inc. acquired a new position in LifePoint Hospitals during the second quarter valued at approximately $111,000. Acrospire Investment Management LLC acquired a new position in LifePoint Hospitals during the first quarter valued at approximately $125,000. Pacad Investment Ltd. acquired a new position in LifePoint Hospitals during the second quarter valued at approximately $141,000. US Bancorp DE raised its position in LifePoint Hospitals by 1.6% in the second quarter. US Bancorp DE now owns 2,316 shares of the company’s stock valued at $152,000 after buying an additional 37 shares during the last quarter. Finally, Bank of Montreal Can acquired a new position in LifePoint Hospitals during the second quarter valued at approximately $168,000. Hedge funds and other institutional investors own 97.10% of the company’s stock.
About LifePoint Hospitals
LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Hospitals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Hospitals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.